Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 364924, 16 pages
http://dx.doi.org/10.1155/2015/364924
Review Article

Primary Retinal Cultures as a Tool for Modeling Diabetic Retinopathy: An Overview

1Department of Cell Biology and Neuroscience, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161 Rome, Italy
2GB Bietti Eye Foundation IRCCS, Via Livenza, 3, 00198 Rome, Italy
3Department of Technology and Health, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161 Rome, Italy

Received 16 September 2014; Revised 4 December 2014; Accepted 23 December 2014

Academic Editor: Michael P. Fautsch

Copyright © 2015 Andrea Matteucci et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. L. Daley, R. C. Watzke, and M. C. Riddle, “Early loss of blue-sensitive color vision in patients with type I diabetes,” Diabetes Care, vol. 10, no. 6, pp. 777–781, 1987. View at Publisher · View at Google Scholar · View at Scopus
  2. M. S. Roy, R. D. Gunkel, and M. J. Podgor, “Color vision defects in early diabetic retinopathy,” Archives of Ophthalmology, vol. 104, no. 2, pp. 225–228, 1986. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Sokol, A. Moskowitz, B. Skarf, R. Evans, M. Molitch, and B. Senior, “Contrast sensitivity in diabetics with and without background retinopathy,” Archives of Ophthalmology, vol. 103, no. 1, pp. 51–54, 1985. View at Publisher · View at Google Scholar · View at Scopus
  4. M. A. Bearse Jr., Y. Han, M. E. Schneck, S. Barez, C. Jacobsen, and A. J. Adams, “Local multifocal oscillatory potential abnormalities in diabetes and early diabetic retinopathy,” Investigative Ophthalmology & Visual Science, vol. 45, no. 9, pp. 3259–3265, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. V. Parisi, L. Uccioli, L. Parisi et al., “Neural conduction in visual pathways in newly-diagnosed IDDM patients,” Electroencephalography and Clinical Neurophysiology—Evoked Potentials, vol. 108, no. 5, pp. 490–496, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Yonemura, T. Aoki, and K. Tsuzuki, “Electroretinogram in diabetic retinopathy,” Archives of Ophthalmology, vol. 68, no. 1, pp. 19–24, 1962. View at Publisher · View at Google Scholar
  7. H. W. van Dijk, F. D. Verbraak, P. H. B. Kok et al., “Early neurodegeneration in the retina of type 2 diabetic patients,” Investigative Ophthalmology and Visual Science, vol. 53, no. 6, pp. 2715–2719, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. D. R. Tomlinson and N. J. Gardiner, “Glucose neurotoxicity,” Nature Reviews Neuroscience, vol. 9, no. 1, pp. 36–45, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. T. S. Kern, “Interrelationships between the retinal neuroglia and vasculature in diabetes,” Diabetes & Metabolism Journal, vol. 38, no. 3, pp. 163–170, 2014. View at Publisher · View at Google Scholar
  10. N. G. Hattangady and M. S. Rajadhyaksha, “A brief review of in vitro models of diabetic neuropathy,” International Journal of Diabetes in Developing Countries, vol. 29, no. 4, pp. 143–149, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A. B. El-Remessy, M. Al-Shabrawey, D. H. Platt et al., “Peroxynitrite mediates VEGF's angiogenic signal and function via a nitration-independent mechanism in endothelial cells,” FASEB Journal, vol. 21, no. 10, pp. 2528–2539, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. T. Nishikawa, D. Edelstein, X. L. Du et al., “Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage,” Nature, vol. 404, no. 6779, pp. 787–790, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. G. Romeo, W. H. Liu, V. Asnaghi, T. S. Kern, and M. Lorenzi, “Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes,” Diabetes, vol. 51, no. 7, pp. 2241–2248, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. B.-H. Chen, D.-Y. Jiang, and L.-S. Tang, “Advanced glycation end-products induce apoptosis involving the signaling pathways of oxidative stress in bovine retinal pericytes,” Life Sciences, vol. 79, no. 11, pp. 1040–1048, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. V. Asnaghi, C. Gerhardinger, T. Hoehn, A. Adeboje, and M. Lorenzi, “A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat,” Diabetes, vol. 52, no. 2, pp. 506–511, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. A. J. Barber, “A new view of diabetic retinopathy: a neurodegenerative disease of the eye,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 27, no. 2, pp. 283–290, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. A. J. Barber, E. Lieth, S. A. Khin, D. A. Antonetti, A. G. Buchanan, and T. W. Gardner, “Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin,” The Journal of Clinical Investigation, vol. 102, no. 4, pp. 783–791, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. D. J. Feenstra, E. C. Yego, and S. Mohr, “Modes of retinal cell death in diabetic retinopathy,” Journal of Clinical & Experimental Ophthalmology, vol. 4, no. 5, p. 298, 2013. View at Publisher · View at Google Scholar
  19. Z. Fu, H.-Y. Kuang, M. Hao, X.-Y. Gao, Y. Liu, and N. Shao, “Protection of exenatide for retinal ganglion cells with different glucose concentrations,” Peptides, vol. 37, no. 1, pp. 25–31, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Liu, T. Lijian, X. Fu, Y. Zhao, and X. Xu, “BDNF protects retinal neurons from hyperglycemia through the TrkB/ERK/MAPK pathway,” Molecular Medicine Reports, vol. 7, no. 6, pp. 1773–1778, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Oshitari, N. Yoshida-Hata, and S. Yamamoto, “Effect of neurotrophin-4 on endoplasmic reticulum stress-related neuronal apoptosis in diabetic and high glucose exposed rat retinas,” Neuroscience Letters, vol. 501, no. 2, pp. 102–106, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. A. J. Barber, T. W. Gardner, and S. F. Abcouwer, “The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy,” Investigative Ophthalmology and Visual Science, vol. 52, no. 2, pp. 1156–1163, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. R. Simó and C. Hernández, “Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives,” Trends in Endocrinology and Metabolism, vol. 25, no. 1, pp. 23–33, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. A. M. Vincent, M. J. Stevens, C. Backus, L. L. Mclean, and E. L. Feldman, “Cell culture modeling to test therapies against hyperglycemia-mediated oxidative stress and injury,” Antioxidants & Redox Signaling, vol. 7, no. 11-12, pp. 1494–1506, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. B. K. Binukumar, Y.-L. Zheng, V. Shukla, N. D. Amin, P. Grant, and H. C. Pant, “TFP5, a peptide derived from p35, a Cdk5 neuronal activator, rescues cortical neurons from glucose toxicity,” Journal of Alzheimer's Disease, vol. 39, no. 4, pp. 899–909, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. R.-H. Yang, J. Lin, X.-H. Hou et al., “Effect of docosahexaenoic acid on hippocampal neurons in high-glucose condition: involvement of PI3K/AKT/nuclear factor-κB-mediated inflammatory pathways,” Neuroscience, vol. 274, pp. 218–228, 2014. View at Publisher · View at Google Scholar
  27. T. Oshitari, N. Yoshida-Hata, and S. Yamamoto, “Effect of neurotrophic factors on neuronal apoptosis and neurite regeneration in cultured rat retinas exposed to high glucose,” Brain Research, vol. 1346, pp. 43–51, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. J. W. Russell, K. A. Sullivan, A. J. Windebank, D. N. Herrmann, and E. L. Feldman, “Neurons undergo apoptosis in animal and cell culture models of diabetes,” Neurobiology of Disease, vol. 6, no. 5, pp. 347–363, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. A. R. Santiago, A. J. Cristóvão, P. F. Santos, C. M. Carvalho, and A. F. Ambrósio, “High glucose induces caspase-independent cell death in retinal neural cells,” Neurobiology of Disease, vol. 25, no. 3, pp. 464–472, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. A. Matteucci, L. Gaddini, M. Villa et al., “Neuroprotection by rat Müller glia against high glucose-induced neurodegeneration through a mechanism involving ERK1/2 activation,” Experimental Eye Research, vol. 125, pp. 20–29, 2014. View at Publisher · View at Google Scholar
  31. G. N. Costa, J. Vindeirinho, C. Cavadas, A. F. Ambrósio, and P. F. Santos, “Contribution of TNF receptor 1 to retinal neural cell death induced by elevated glucose,” Molecular and Cellular Neuroscience, vol. 50, no. 1, pp. 113–123, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. A. R. Santiago, S. C. Rosa, P. F. Santos, A. J. Cristóvão, A. J. Barber, and A. F. Ambrósio, “Elevated glucose changes the expression of ionotropic glutamate receptor subunits and impairs calcium homeostasis in retinal neural cells,” Investigative Ophthalmology & Visual Science, vol. 47, no. 9, pp. 4130–4137, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. X. Xi, L. Gao, D. A. Hatala et al., “Chronically elevated glucose-induced apoptosis is mediated by inactivation of Akt in cultured Müller cells,” Biochemical and Biophysical Research Communications, vol. 326, no. 3, pp. 548–553, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Lecleire-Collet, L. H. Tessier, P. Massin et al., “Advanced glycation end products can induce glial reaction and neuronal degeneration in retinal explants,” The British Journal of Ophthalmology, vol. 89, no. 12, pp. 1631–1633, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. A. M. Abu El-Asrar, L. Dralands, L. Missotten, I. A. Al-Jadaan, and K. Geboes, “Expression of apoptosis markers in the retinas of human subjects with diabetes,” Investigative Ophthalmology and Visual Science, vol. 45, no. 8, pp. 2760–2766, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. H. P. Hammes, H. J. Federoff, and M. Brownlee, “Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes,” Molecular Medicine (Cambridge, Mass.), vol. 1, no. 5, pp. 527–534, 1995. View at Google Scholar · View at Scopus
  37. T. S. Kern and A. J. Barber, “Retinal ganglion cells in diabetes,” The Journal of Physiology, vol. 586, no. 18, pp. 4401–4408, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. A. Y. Shanab, T. Nakazawa, M. Ryu et al., “Metabolic stress response implicated in diabetic retinopathy: the role of calpain, and the therapeutic impact of calpain inhibitor,” Neurobiology of Disease, vol. 48, no. 3, pp. 556–567, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. M. Takano, K. Sango, H. Horie et al., “Diabetes alters neurite regeneration from mouse retinal explants in culture,” Neuroscience Letters, vol. 275, no. 3, pp. 175–178, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Oshitari, G. Bikbova, and S. Yamamoto, “Increased expression of phosphorylated c-Jun and phosphorylated c-Jun N-terminal kinase associated with neuronal cell death in diabetic and high glucose exposed rat retinas,” Brain Research Bulletin, vol. 101, pp. 18–25, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Seki, T. Tanaka, H. Nawa et al., “Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells,” Diabetes, vol. 53, no. 9, pp. 2412–2419, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Ozawa, T. Kurihara, M. Sasaki et al., “Neural degeneration in the retina of the streptozotocin-induced type 1 diabetes model,” Experimental Diabetes Research, vol. 2011, Article ID 108328, 7 pages, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. S.-H. Park, J.-W. Park, S.-J. Park et al., “Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina,” Diabetologia, vol. 46, no. 9, pp. 1260–1268, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. B. A. Mysona, A. Y. Shanab, S. L. Elshaer, and A. B. El-Remessy, “Nerve growth factor in diabetic retinopathy: beyond neurons,” Expert Review of Ophthalmology, vol. 9, no. 2, pp. 99–107, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. F. Chiarelli, F. Santilli, and A. Mohn, “Role of growth factors in the development of diabetic complications,” Hormone Research, vol. 53, no. 2, pp. 53–67, 2000. View at Google Scholar · View at Scopus
  46. J. D. Unterlauft, T. Claudepierre, M. Schmidt et al., “Enhanced survival of retinal ganglion cells is mediated by Müller glial cell-derived PEDF,” Experimental Eye Research, vol. 127, pp. 206–214, 2014. View at Publisher · View at Google Scholar
  47. F. Mantelli, A. Lambiase, V. Colafrancesco, M. L. Rocco, I. Macchi, and L. Aloe, “NGF and VEGF effects on retinal ganglion cell fate: new evidence from an animal model of diabetes,” European Journal of Ophthalmology, vol. 24, no. 2, pp. 247–253, 2014. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. A. M. Abu El-Asrar, G. Mohammad, G. de Hertogh et al., “Neurotrophins and neurotrophin receptors in proliferative diabetic retinopathy,” PLoS ONE, vol. 8, no. 6, Article ID e65472, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. T. K. Ali, M. M. H. Al-Gayyar, S. Matragoon et al., “Diabetes-induced peroxynitrite impairs the balance of pro-nerve growth factor and nerve growth factor, and causes neurovascular injury,” Diabetologia, vol. 54, no. 3, pp. 657–668, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. T. K. Ali, S. Matragoon, B. A. Pillai, G. I. Liou, and A. B. El-Remessy, “Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes,” Diabetes, vol. 57, no. 4, pp. 889–898, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. M. M. H. Al-Gayyar, S. Matragoon, B. A. Pillai, T. K. Ali, M. A. Abdelsaid, and A. B. El-Remessy, “Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor proNGF expression in a rat model of diabetes,” Diabetologia, vol. 54, no. 3, pp. 669–680, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. C. Sippl and E. R. Tamm, “What is the nature of the RGC-5 cell line?” in Retinal Degenerative Diseases, vol. 801 of Advances in Experimental Medicine and Biology, pp. 145–154, Springer, New York, NY, USA, 2014. View at Publisher · View at Google Scholar
  53. J. Atkinson, M. K. Panni, and R. D. Lund, “Effects of neurotrophins on embryonic retinal outgrowth,” Developmental Brain Research, vol. 112, no. 2, pp. 173–180, 1999. View at Publisher · View at Google Scholar · View at Scopus
  54. M. G. Lykissas, A. K. Batistatou, K. A. Charalabopoulos, and A. E. Beris, “The role of neurotrophins in axonal growth, guidance, and regeneration,” Current Neurovascular Research, vol. 4, no. 2, pp. 143–151, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Matteucci, M. Varano, L. Gaddini et al., “Neuroprotective effects of citicoline in in vitro models of retinal neurodegeneration,” International Journal of Molecular Sciences, vol. 15, no. 4, pp. 6286–6297, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. L. M. Hu, Y. Luo, J. Zhang et al., “EPO reduces reactive gliosis and stimulates neurotrophin expression in Muller cells,” Frontiers in Bioscience (Elite Edition), vol. 3, pp. 1541–1555, 2011. View at Google Scholar
  57. A. Bringmann, T. Pannicke, J. Grosche et al., “Müller cells in the healthy and diseased retina,” Progress in Retinal and Eye Research, vol. 25, no. 4, pp. 397–424, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. A. Reichenbach and A. Bringmann, “New functions of Muller cells,” Glia, vol. 61, no. 5, pp. 651–678, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. A. J. Barber, D. A. Antonetti, and T. W. Gardner, “Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group,” Investigative Ophthalmology and Visual Science, vol. 41, no. 11, pp. 3561–3568, 2000. View at Google Scholar · View at Scopus
  60. E. Lieth, A. J. Barber, B. Xu et al., “Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy,” Diabetes, vol. 47, no. 5, pp. 815–820, 1998. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Mizutani, C. Gerhardinger, and M. Lorenzi, “Muller cell changes in human diabetic retinopathy,” Diabetes, vol. 47, no. 3, pp. 445–449, 1998. View at Publisher · View at Google Scholar · View at Scopus
  62. E. Rungger-Brändle, A. A. Dosso, and P. M. Leuenberger, “Glial reactivity, an early feature of diabetic retinopathy,” Investigative Ophthalmology & Visual Science, vol. 41, no. 7, pp. 1971–1980, 2000. View at Google Scholar · View at Scopus
  63. A. Bringmann, T. Pannicke, M. Weick et al., “Activation of P2Y receptors stimulates potassium and cation currents in acutely isolated human Müller (glial) cells,” GLIA, vol. 37, no. 2, pp. 139–152, 2002. View at Publisher · View at Google Scholar · View at Scopus
  64. E. Ulbricht, T. Pannicke, M. Hollborn et al., “Proliferative gliosis causes mislocation and inactivation of inwardly rectifying K(+) (Kir) channels in rabbit retinal glial cells,” Experimental Eye Research, vol. 86, no. 2, pp. 305–313, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. Q. Li and D. G. Puro, “Diabetes-induced dysfunction of the glutamate transporter in retinal Müller cells,” Investigative Ophthalmology and Visual Science, vol. 43, no. 9, pp. 3109–3116, 2002. View at Google Scholar · View at Scopus
  66. E. Lieth, K. F. LaNoue, D. A. Antonetti, and M. Ratz, “Diabetes reduces glutamate oxidation and glutamine synthesis in the retina. The Penn State Retina Research Group,” Experimental Eye Research, vol. 70, no. 6, pp. 723–730, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. B. Kumar, S. K. Gupta, T. C. Nag et al., “Retinal neuroprotective effects of quercetin in streptozotocin-induced diabetic rats,” Experimental Eye Research, vol. 125, pp. 193–202, 2014. View at Publisher · View at Google Scholar
  68. C. Gerhardinger, M. B. Costa, M. C. Coulombe, I. Toth, T. Hoehn, and P. Grosu, “Expression of acute-phase response proteins in retinal Müller cells in diabetes,” Investigative Ophthalmology & Visual Science, vol. 46, no. 1, pp. 349–357, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. T. S. Kern, “Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy,” Experimental Diabetes Research, vol. 2007, Article ID 95103, 14 pages, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  70. X. Shen, Y. Zhong, B. Xie, Y. Cheng, and Q. Jiao, “Pigment epithelium derived factor as an anti-inflammatory factor against decrease of glutamine synthetase expression in retinal Müller cells under high glucose conditions,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 248, no. 8, pp. 1127–1136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. J. Tang and T. S. Kern, “Inflammation in diabetic retinopathy,” Progress in Retinal and Eye Research, vol. 30, no. 5, pp. 343–358, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  72. F. R. Vázquez-Chona, A. Swan, W. D. Ferrell et al., “Proliferative reactive gliosis is compatible with glial metabolic support and neuronal function,” BMC Neuroscience, vol. 12, article 98, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Honjo, H. Tanihara, N. Kido, M. Inatani, K. Okazaki, and Y. Honda, “Expression of ciliary neurotrophic factor activated by retinal Muller cells in eyes with NMDA- and kainic acid-induced neuronal death,” Investigative Ophthalmology & Visual Science, vol. 41, no. 2, pp. 552–560, 2000. View at Google Scholar · View at Scopus
  74. T. G. Hauk, A. Müller, J. Lee, R. Schwendener, and D. Fischer, “Neuroprotective and axon growth promoting effects of intraocular inflammation do not depend on oncomodulin or the presence of large numbers of activated macrophages,” Experimental Neurology, vol. 209, no. 2, pp. 469–482, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  75. B. Lorber, M. Berry, M. R. Douglas, T. Nakazawa, and A. Logan, “Activated retinal glia promote neurite outgrowth of retinal ganglion cells via apolipoprotein E,” Journal of Neuroscience Research, vol. 87, no. 12, pp. 2645–2652, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. A. Bringmann, I. Iandiev, T. Pannicke et al., “Cellular signaling and factors involved in Müller cell gliosis: neuroprotective and detrimental effects,” Progress in Retinal and Eye Research, vol. 28, no. 6, pp. 423–451, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  77. J. Middeldorp and E. M. Hol, “GFAP in health and disease,” Progress in Neurobiology, vol. 93, no. 3, pp. 421–443, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  78. H. Zong, M. Ward, A. Madden et al., “Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia are regulated by the receptor for advanced glycation end-products (RAGE),” Diabetologia, vol. 53, no. 12, pp. 2656–2666, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  79. Y. Du, V. P. Sarthy, and T. S. Kern, “Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 287, no. 4, pp. R735–R741, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  80. J. W. Miller, A. P. Adamis, and L. P. Aiello, “Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy,” Diabetes/Metabolism Reviews, vol. 13, no. 1, pp. 37–50, 1997. View at Publisher · View at Google Scholar
  81. R. B. Caldwell, M. Bartoli, M. A. Behzadian et al., “Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives,” Diabetes/Metabolism Research and Reviews, vol. 19, no. 6, pp. 442–455, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  82. J. Tombran-Tink and C. J. Barnstable, “PEDF: a multifaceted neurotrophic factor,” Nature Reviews Neuroscience, vol. 4, no. 8, pp. 628–636, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  83. J. Tombran-Tink, “PEDF in angiogenic eye diseases,” Current Molecular Medicine, vol. 10, no. 3, pp. 267–278, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. H. Mu, X.-M. Zhang, J.-J. Liu, L. Dong, and Z.-L. Feng, “Effect of high glucose concentration on VEGF and PEDF expression in cultured retinal Müller cells,” Molecular Biology Reports, vol. 36, no. 8, pp. 2147–2151, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  85. B. Xie, Q. Jiao, Y. Cheng, Y. Zhong, and X. Shen, “Effect of pigment epithelium-derived factor on glutamate uptake in retinal müller cells under high-glucose conditions,” Investigative Ophthalmology & Visual Science, vol. 53, no. 2, pp. 1023–1032, 2012. View at Publisher · View at Google Scholar · View at Scopus
  86. T. Muto, T. Tien, D. Kim, V. P. Sarthy, and S. Roy, “High glucose alters Cx43 expression and gap junction intercellular communication in retinal Muller cells: promotes muller cell and pericyte apoptosis,” Investigative Ophthalmology & Visual Science, vol. 55, no. 7, pp. 4327–4337, 2014. View at Publisher · View at Google Scholar
  87. Y. Jiang, J. Pagadala, D. Miller, and J. J. Steinle, “Reduced insulin receptor signaling in retinal Müller cells cultured in high glucose,” Molecular Vision, vol. 19, pp. 804–811, 2013. View at Google Scholar · View at Scopus
  88. L. L. Kusner, V. P. Sarthy, and S. Mohr, “Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal Müller cells,” Investigative Ophthalmology and Visual Science, vol. 45, no. 5, pp. 1553–1561, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  89. R. J. Walker, N. M. Anderson, S. Bahouth, and J. J. Steinle, “Silencing of insulin receptor substrate-1 increases cell death in retinal müller cells,” Molecular Vision, vol. 18, pp. 271–279, 2012. View at Google Scholar · View at Scopus
  90. E. Chavira-Suárez, A. Sandoval, R. Felix, and M. Lamas, “Expression and high glucose-mediated regulation of K+ channel interacting protein 3 (KChIP3) and KV4 channels in retinal Müller glial cells,” Biochemical and Biophysical Research Communications, vol. 404, no. 2, pp. 678–683, 2011. View at Publisher · View at Google Scholar · View at Scopus
  91. P. Jayaguru and S. Mohr, “Nuclear GAPDH: changing the fate of Müller cells in diabetes,” Journal of Ocular Biology, Diseases, and Informatics, vol. 4, no. 1-2, pp. 34–41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  92. T. Bergsbaken, S. L. Fink, and B. T. Cookson, “Pyroptosis: host cell death and inflammation,” Nature Reviews Microbiology, vol. 7, no. 2, pp. 99–109, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  93. K. E. Trueblood, S. Mohr, and G. R. Dubyak, “Purinergic regulation of high-glucose-induced caspase-1 activation in the rat retinal Müller cell line rMC-1,” American Journal of Physiology: Cell Physiology, vol. 301, no. 5, pp. C1213–C1223, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  94. E. C. K. Yego, J. A. Vincent, V. Sarthy, J. V. Busik, and S. Mohr, “Differential regulation of high glucose-induced glyceraldehyde-3-phosphate dehydrogenase nuclear accumulation in müller cells by IL-1beta and IL-6,” Investigative Ophthalmology & Visual Science, vol. 50, no. 4, pp. 1920–1928, 2009. View at Publisher · View at Google Scholar · View at Scopus
  95. H.-P. Hammes, Y. Feng, F. Pfister, and M. Brownlee, “Diabetic retinopathy: targeting vasoregression,” Diabetes, vol. 60, no. 1, pp. 9–16, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  96. F. Giacco and M. Brownlee, “Oxidative stress and diabetic complications,” Circulation Research, vol. 107, no. 9, pp. 1058–1070, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  97. A. K. Berner, O. Brouwers, R. Pringle et al., “Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology,” Diabetologia, vol. 55, no. 3, pp. 845–854, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  98. T. Nishikawa, D. Edelstein, and M. Brownlee, “The missing link: a single unifying mechanism for diabetic complications,” Kidney International, Supplement, vol. 58, no. 77, pp. S26–S30, 2000. View at Publisher · View at Google Scholar · View at Scopus
  99. F. Pricci, G. Leto, L. Amadio et al., “Oxidative stress in diabetes-induced endothelial dysfunction involvement of nitric oxide and protein kinase C,” Free Radical Biology & Medicine, vol. 35, no. 6, pp. 683–694, 2003. View at Publisher · View at Google Scholar · View at Scopus
  100. C. Iacobini, L. Amadio, G. Oddi et al., “Role of galectin-3 in diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 14, no. supplement 3, pp. S264–S270, 2003. View at Publisher · View at Google Scholar · View at Scopus
  101. U. Di Mario and G. Pugliese, “15th Golgi lecture: from hyperglycaemia to the dysregulation of vascular remodelling in diabetes,” Diabetologia, vol. 44, no. 6, pp. 674–692, 2001. View at Publisher · View at Google Scholar · View at Scopus
  102. G. Pugliese, F. Pricci, G. Leto et al., “The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression,” Diabetes, vol. 49, no. 7, pp. 1249–1257, 2000. View at Publisher · View at Google Scholar · View at Scopus
  103. M. Chen, T. M. Curtis, and A. W. Stitt, “Advanced glycation end products and diabetic retinopathy,” Current Medicinal Chemistry, vol. 20, no. 26, pp. 3234–3240, 2013. View at Publisher · View at Google Scholar · View at Scopus
  104. A. W. Stitt, N. Lois, R. J. Medina, P. Adamson, and T. M. Curtis, “Advances in our understanding of diabetic retinopathy,” Clinical Science, vol. 125, no. 1, pp. 1–17, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  105. A. W. Stitt and T. M. Curtis, “Diabetes-related adduct formation and retinopathy,” Journal of Ocular Biology, Diseases, and Informatics, vol. 4, no. 1-2, pp. 10–18, 2011. View at Publisher · View at Google Scholar · View at Scopus
  106. H. Zong, M. Ward, and A. W. Stitt, “AGEs, RAGE, and diabetic retinopathy,” Current Diabetes Reports, vol. 11, no. 4, pp. 244–252, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  107. T. M. Curtis, R. Hamilton, P.-H. Yong et al., “Müller glial dysfunction during diabetic retinopathy in rats is linked to accumulation of advanced glycation end-products and advanced lipoxidation end-products,” Diabetologia, vol. 54, no. 3, pp. 690–698, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  108. A. W. Stitt, “AGEs and diabetic retinopathy,” Investigative Ophthalmology & Visual Science, vol. 51, no. 10, pp. 4867–4874, 2010. View at Publisher · View at Google Scholar · View at Scopus
  109. H. Vlassara and G. E. Striker, “Advanced glycation endproducts in diabetes and diabetic complications,” Endocrinology and Metabolism Clinics of North America, vol. 42, no. 4, pp. 697–719, 2013. View at Publisher · View at Google Scholar · View at Scopus
  110. R. A. Kowluru and P. S. Chan, “Oxidative stress and diabetic retinopathy,” Experimental Diabesity Research, vol. 2007, Article ID 43603, 12 pages, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  111. S. A. Madsen-Bouterse and R. A. Kowluru, “Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives,” Reviews in Endocrine and Metabolic Disorders, vol. 9, no. 4, pp. 315–327, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  112. L. Zheng and T. S. Kern, “Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy,” Frontiers in Bioscience (Landmark Edition), vol. 14, no. 10, pp. 3974–3987, 2009. View at Google Scholar · View at Scopus
  113. R. A. Kowluru, “Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditions,” Life Sciences, vol. 76, no. 9, pp. 1051–1060, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  114. O. Goureau, F. Régnier-Ricard, and Y. Courtois, “Requirement for nitric oxide in retinal neuronal cell death induced by activated Muller glial cells,” Journal of Neurochemistry, vol. 72, no. 6, pp. 2506–2515, 1999. View at Publisher · View at Google Scholar · View at Scopus
  115. A. B. El-Remessy, M. Bartoli, D. H. Platt, D. Fulton, and R. B. Caldwell, “Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration,” Journal of Cell Science, vol. 118, no. 1, pp. 243–252, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  116. J. M. Gaspar, A. Martins, R. Cruz, C. M. P. Rodrigues, A. F. Ambrósio, and A. R. Santiago, “Tauroursodeoxycholic acid protects retinal neural cells from cell death induced by prolonged exposure to elevated glucose,” Neuroscience, vol. 253, pp. 380–388, 2013. View at Publisher · View at Google Scholar · View at Scopus
  117. Y. Du, M. A. Smith, C. M. Miller, and T. S. Kern, “Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine,” Journal of Neurochemistry, vol. 80, no. 5, pp. 771–779, 2002. View at Publisher · View at Google Scholar · View at Scopus
  118. R. Milne and S. Brownstein, “Advanced glycation end products and diabetic retinopathy,” Amino Acids, vol. 44, no. 6, pp. 1397–1407, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  119. R. Ramasamy, S. F. Yan, and A. M. Schmidt, “Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications,” Annals of the New York Academy of Sciences, vol. 1243, no. 1, pp. 88–102, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  120. F. Pricci, G. Leto, L. Amadio et al., “Role of galectin-3 as a receptor for advanced glycosylation end products,” Kidney International, Supplement, vol. 58, no. 77, pp. S31–S39, 2000. View at Publisher · View at Google Scholar · View at Scopus
  121. V. Scivittaro, M. B. Ganz, and M. F. Weiss, “AGEs induce oxidative stress and activate protein kinase C-β(II) in neonatal mesangial cells,” The American Journal of Physiology—Renal Physiology, vol. 278, no. 4, pp. F676–F683, 2000. View at Google Scholar · View at Scopus
  122. A. W. Stitt, “The role of advanced glycation in the pathogenesis of diabetic retinopathy,” Experimental and Molecular Pathology, vol. 75, no. 1, pp. 95–108, 2003. View at Publisher · View at Google Scholar · View at Scopus
  123. H. Vlassara, W. Cai, J. Crandall et al., “Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 24, pp. 15596–15601, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  124. G. Bikbova, T. Oshitari, and S. Yamamoto, “Neurite regeneration in adult rat retinas exposed to advanced glycation end-products and regenerative effects of neurotrophin-4,” Brain Research, vol. 1534, pp. 33–45, 2013. View at Publisher · View at Google Scholar · View at Scopus
  125. T. Kobayashi, H. Oku, A. Komori et al., “Advanced glycation end products induce death of retinal neurons via activation of nitric oxide synthase,” Experimental Eye Research, vol. 81, no. 6, pp. 647–654, 2005. View at Publisher · View at Google Scholar · View at Scopus
  126. F. Reber, R. Geffarth, M. Kasper et al., “Graded sensitiveness of the various retinal neuron populations on the glyoxal-medical formation of advanced glycation end products and ways of protection,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 241, no. 3, pp. 213–225, 2003. View at Publisher · View at Google Scholar · View at Scopus
  127. F. Reber, M. Kasper, A. Siegner, E. Kniep, G. Seigel, and R. H. W. Funk, “Alteration of the intracellular pH and apoptosis induction in a retinal cell line by the AGE-inducing agent glyoxal,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 240, no. 12, pp. 1022–1032, 2002. View at Publisher · View at Google Scholar · View at Scopus
  128. N. Dong, X. Li, L. Xiao, W. Yu, B. Wang, and L. Chu, “Upregulation of retinal neuronal MCP-1 in the rodent model of diabetic retinopathy and its function in vitro,” Investigative Ophthalmology & Visual Science, vol. 53, no. 12, pp. 7567–7575, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  129. A. Mehta, M. Prabhakar, P. Kumar, R. Deshmukh, and P. L. Sharma, “Excitotoxicity: bridge to various triggers in neurodegenerative disorders,” European Journal of Pharmacology, vol. 698, no. 1–3, pp. 6–18, 2013. View at Publisher · View at Google Scholar · View at Scopus
  130. M. Ishikawa, “Abnormalities in glutamate metabolism and excitotoxicity in the retinal diseases,” Scientifica, vol. 2013, Article ID 528940, 13 pages, 2013. View at Publisher · View at Google Scholar
  131. C. Romano, Q. Chen, and J. W. Olney, “The intact isolated (ex vivo) retina as a model system for the study of excitotoxicity,” Progress in Retinal and Eye Research, vol. 17, no. 4, pp. 465–483, 1998. View at Publisher · View at Google Scholar · View at Scopus
  132. C. K. Vorwerk, B. T. Hyman, J. W. Miller et al., “The role of neuronal and endothelial nitric oxide synthase in retinal excitotoxicity,” Investigative Ophthalmology & Visual Science, vol. 38, no. 10, pp. 2038–2044, 1997. View at Google Scholar · View at Scopus
  133. J. E. Pulido, J. S. Pulido, J. C. Erie et al., “A role for excitatory amino acids in diabetic eye disease,” Experimental Diabesity Research, vol. 2007, Article ID 36150, 7 pages, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  134. J. Ambati, K. V. Chalam, D. K. Chawala et al., “Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy,” Archives of Ophthalmology, vol. 115, no. 9, pp. 1161–1166, 1997. View at Publisher · View at Google Scholar · View at Scopus
  135. R. A. Kowluru, R. L. Engerman, G. L. Case, and T. S. Kern, “Retinal glutamate in diabetes and effect of antioxidants,” Neurochemistry International, vol. 38, no. 5, pp. 385–390, 2001. View at Publisher · View at Google Scholar · View at Scopus
  136. J. C. M. Lau, R. A. Kroes, J. R. Moskal, and R. A. Linsenmeier, “Diabetes changes expression of genes related to glutamate neurotransmission and transport in the Long-Evans rat retina,” Molecular Vision, vol. 19, pp. 1538–1553, 2013. View at Google Scholar · View at Scopus
  137. V. Heidinger, D. Hicks, J. Sahel, and H. Dreyfus, “Ability of retinal Muller glial cells to protect neurons against excitotoxicity in vitro depends upon maturation and neuron-glial interactions,” Glia, vol. 25, no. 3, pp. 229–239, 1999. View at Publisher · View at Google Scholar
  138. A. M. López-Colomé, Z. Martínez-Lozada, A. M. Guillem, E. López, and A. Ortega, “Glutamate transporter-dependent mTOR phosphorylation in Müller glia cells,” ASN Neuro, vol. 4, no. 5, pp. 331–342, 2012. View at Publisher · View at Google Scholar
  139. N. Niyadurupola, P. Sidaway, N. Ma, J. D. Rhodes, D. C. Broadway, and J. Sanderson, “P2X7 receptor activation mediates retinal ganglion cell death in a human retina model of ischemic neurodegeneration,” Investigative Ophthalmology and Visual Science, vol. 54, no. 3, pp. 2163–2170, 2013. View at Publisher · View at Google Scholar · View at Scopus
  140. C. Zhang, H. Li, M.-G. Liu et al., “STAT3 activation protects retinal ganglion cell layer neurons in response to stress,” Experimental Eye Research, vol. 86, no. 6, pp. 991–997, 2008. View at Publisher · View at Google Scholar · View at Scopus
  141. N. Froger, L. Cadetti, H. Lorach et al., “Taurine Provides Neuroprotection against Retinal Ganglion Cell Degeneration,” PLoS ONE, vol. 7, no. 10, Article ID e42017, 2012. View at Publisher · View at Google Scholar · View at Scopus
  142. D. C. Baptiste, A. T. E. Hartwick, C. A. B. Jollimore et al., “Comparison of the neuroprotective effects of adrenoceptor drugs in retinal cell culture and intact retina,” Investigative Ophthalmology & Visual Science, vol. 43, no. 8, pp. 2666–2676, 2002. View at Google Scholar · View at Scopus
  143. A. Matteucci, R. Cammarota, S. Paradisi et al., “Curcumin protects against NMDA-induced toxicity: a possible role for NR2A subunit,” Investigative Ophthalmology and Visual Science, vol. 52, no. 2, pp. 1070–1077, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  144. K. Ruscher, S. Rzeczinski, E. Thein et al., “Neuroprotective effects of the β-carboline abecarnil studied in cultured cortical neurons and organotypic retinal cultures,” Neuropharmacology, vol. 52, no. 7, pp. 1488–1495, 2007. View at Publisher · View at Google Scholar · View at Scopus
  145. A. M. Joussen, V. Poulaki, M. L. Le et al., “A central role for inflammation in the pathogenesis of diabetic retinopathy,” The FASEB Journal, vol. 18, no. 12, pp. 1450–1452, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  146. A. M. A. El Asrar, D. Maimone, P. H. Morse, S. Gregory, and A. T. Reder, “Cytokines in the vitreous of patients with proliferative diabetic retinopathy,” The American Journal of Ophthalmology, vol. 114, no. 6, pp. 731–736, 1992. View at Publisher · View at Google Scholar · View at Scopus
  147. G. A. Limb, J. Hickman-Casey, R. D. Hollifield, and A. H. Chignell, “Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy,” Investigative Ophthalmology & Visual Science, vol. 40, no. 10, pp. 2453–2457, 1999. View at Google Scholar · View at Scopus
  148. T. Yuuki, T. Kanda, Y. Kimura et al., “Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy,” Journal of Diabetes and its Complications, vol. 15, no. 5, pp. 257–259, 2001. View at Publisher · View at Google Scholar · View at Scopus
  149. H. Funatsu, H. Yamashita, H. Noma, E. Shimizu, T. Mimura, and S. Hori, “Prediction of macular edema exacerbation after phacoemulsification in patients with nonproliferative diabetic retinopathy,” Journal of Cataract and Refractive Surgery, vol. 28, no. 8, pp. 1355–1363, 2002. View at Publisher · View at Google Scholar · View at Scopus
  150. J. K. Krady, A. Basu, C. M. Allen et al., “Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy,” Diabetes, vol. 54, no. 5, pp. 1559–1565, 2005. View at Publisher · View at Google Scholar · View at Scopus
  151. B. Fogal and S. J. Hewett, “Interleukin-1beta: A bridge between inflammation and excitotoxicity?” Journal of Neurochemistry, vol. 106, no. 1, pp. 1–23, 2008. View at Publisher · View at Google Scholar · View at Scopus
  152. G. Tezel, “TNF-alpha signaling in glaucomatous neurodegeneration,” Progress in Brain Research, vol. 173, pp. 409–421, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  153. S. F. Abcouwer, S. Shanmugam, P. F. Gomez et al., “Effect of IL-1β on survival and energy metabolism of R28 and RGC-5 retinal neurons,” Investigative Ophthalmology & Visual Science, vol. 49, no. 12, pp. 5581–5592, 2008. View at Publisher · View at Google Scholar · View at Scopus
  154. M. Wang and W. T. Wong, “Microglia-Müller cell interactions in the retina,” in Retinal Degenerative Diseases, vol. 801 of Advances in Experimental Medicine and Biology, pp. 333–338, Springer, New York, NY, USA, 2014. View at Publisher · View at Google Scholar
  155. G. M. Seigel, “The golden age of retinal cell culture,” Molecular Vision, vol. 5, article 4, 1999. View at Google Scholar · View at Scopus
  156. T. Hartung, “Food for thought... on cell culture,” Altex, vol. 24, no. 3, pp. 143–152, 2007. View at Google Scholar · View at Scopus
  157. T. Hartung and G. Daston, “Are In Vitro tests suitable for regulatory use?” Toxicological Sciences, vol. 111, no. 2, pp. 233–237, 2009. View at Publisher · View at Google Scholar · View at Scopus
  158. S. Coecke, H. Ahr, B. J. Blaauboer et al., “Metabolism: a bottleneck in in vitro toxicological test development. The report and recommendations of ECVAM workshop 54,” Alternatives to Laboratory Animals, vol. 34, no. 1, pp. 49–84, 2006. View at Google Scholar
  159. A. S. Viczian, “Advances in retinal stem cell biology,” Journal of Ophthalmic & Vision Research, vol. 8, no. 2, pp. 147–159, 2013. View at Google Scholar · View at Scopus
  160. M. A. Lancaster and J. A. Knoblich, “Organogenesis in a dish: modeling development and disease using organoid technologies,” Science, vol. 345, no. 6194, Article ID 1247125, 2014. View at Publisher · View at Google Scholar
  161. K.-S. Vellonen, M. Malinen, E. Mannermaa et al., “A critical assessment of in vitro tissue models for ADME and drug delivery,” Journal of Controlled Release, vol. 190, pp. 94–114, 2014. View at Publisher · View at Google Scholar
  162. K. J. Wahlin, J. Maruotti, and D. J. Zack, “Modeling retinal dystrophies using patient-derived induced pluripotent stem cells,” in Retinal Degenerative Diseases, vol. 801 of Advances in Experimental Medicine and Biology, pp. 157–164, Springer, New York, NY, USA, 2014. View at Publisher · View at Google Scholar
  163. A. Matteucci, G. Formisano, S. Paradisi et al., “Biocompatibility assessment of liquid artificial vitreous replacements: relevance of in vitro studies,” Survey of Ophthalmology, vol. 52, no. 3, pp. 289–299, 2007. View at Publisher · View at Google Scholar · View at Scopus
  164. K. J. Marler, P. Suetterlin, A. Dopplapudi et al., “BDNF promotes axon branching of retinal ganglion cells via miRNA-132 and p250GAP,” The Journal of Neuroscience, vol. 34, no. 3, pp. 969–979, 2014. View at Publisher · View at Google Scholar · View at Scopus
  165. M. Rapp, G. Woo, M. R. Al-Ubaidi, S. P. Becerra, and P. Subramanian, “Pigment epithelium-derived factor protects cone photoreceptor-derived 661 W cells from light damage through Akt activation,” Advances in Experimental Medicine and Biology, vol. 801, pp. 813–820, 2014. View at Google Scholar
  166. M. Kikuchi, S. Kashii, M. Mandai et al., “Protective effects of FK506 against glutamate-induced neurotoxicity in retinal cell culture,” Investigative Ophthalmology and Visual Science, vol. 39, no. 7, pp. 1227–1232, 1998. View at Google Scholar · View at Scopus
  167. W. Goto, M. Ichikawa, E. Tanaka, H. Hara, and M. Araie, “Bunazosin hydrochloride reduces glutamate-induced neurotoxicity in rat primary retinal cultures,” Brain Research, vol. 1003, no. 1-2, pp. 130–137, 2004. View at Publisher · View at Google Scholar · View at Scopus
  168. K. Ikeda, T. Tatsuno, H. Noguchi, and C. Nakayama, “Ciliary neurotrophic factor protects rat retina cells in vitro and in vivo via PI3 kinase,” Current Eye Research, vol. 29, no. 4-5, pp. 349–355, 2004. View at Publisher · View at Google Scholar · View at Scopus
  169. C. J. Layton, J. P. M. Wood, G. Chidlow, and N. N. Osborne, “Neuronal death in primary retinal cultures is related to nitric oxide production, and is inhibited by erythropoietin in a glucose-sensitive manner,” Journal of Neurochemistry, vol. 92, no. 3, pp. 487–493, 2005. View at Publisher · View at Google Scholar · View at Scopus
  170. H. Hara, M. Ichikawa, H. Oku, M. Shimazawa, and M. Araie, “Bunazosin, a selective α1-adrenoceptor antagonist, as an anti-glaucoma drug: effects on ocular circulation and retinal neuronal damage,” Cardiovascular Drug Reviews, vol. 23, no. 1, pp. 43–56, 2005. View at Google Scholar · View at Scopus
  171. S. Oono, T. Kurimoto, T. Nakazawa et al., “Pyroglutamic acid promotes survival of retinal ganglion cells after optic nerve injury,” Current Eye Research, vol. 34, no. 7, pp. 598–605, 2009. View at Publisher · View at Google Scholar · View at Scopus
  172. W. Zhou, X. Zhu, L. Zhu et al., “Neuroprotection of muscarinic receptor agonist pilocarpine against glutamate-induced apoptosis in retinal neurons,” Cellular and Molecular Neurobiology, vol. 28, no. 2, pp. 263–275, 2008. View at Publisher · View at Google Scholar · View at Scopus
  173. P.-P. Tan, H.-H. Yuan, X. Zhu et al., “Activation of muscarinic receptors protects against retinal neurons damage and optic nerve degeneration in vitro and in vivo models,” CNS Neuroscience and Therapeutics, vol. 20, no. 3, pp. 227–236, 2014. View at Publisher · View at Google Scholar · View at Scopus
  174. A. R. Santiago, J. M. Hughes, W. Kamphuis, R. O. Schlingemann, and A. F. Ambrósio, “Diabetes changes ionotropic glutamate receptor subunit expression level in the human retina,” Brain Research, vol. 1198, pp. 153–159, 2008. View at Publisher · View at Google Scholar · View at Scopus
  175. A. F. Castilho, J. T. Liberal, F. I. Baptista, J. M. Gaspar, A. L. Carvalho, and A. F. Ambrósio, “Elevated glucose concentration changes the content and cellular localization of AMPA receptors in the retina but not in the hippocampus,” Neuroscience, vol. 219, pp. 23–32, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  176. J. Vindeirinho, G. N. Costa, M. B. Correia, C. Cavadas, and P. F. Santos, “Effect of diabetes/hyperglycemia on the rat retinal adenosinergic system,” PLoS ONE, vol. 8, no. 6, Article ID e67499, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  177. D. Giugliano, A. Ceriello, and G. Paolisso, “Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress?” Metabolism: Clinical and Experimental, vol. 44, no. 3, pp. 363–368, 1995. View at Publisher · View at Google Scholar · View at Scopus
  178. M. Harun-Or-Rashid, N. Lindqvist, and F. Hallbook, “Transactivation of EGF receptors in chicken Muller cells by alpha2A-adrenergic receptors stimulated by brimonidine,” Investigative Ophthalmology & Visual Science, vol. 55, no. 6, pp. 3385–3394, 2014. View at Google Scholar
  179. D. Hicks and Y. Courtois, “The growth and behaviour of rat retinal muller cells in vitro. 1. An improved method for isolation and culture,” Experimental Eye Research, vol. 51, no. 2, pp. 119–129, 1990. View at Publisher · View at Google Scholar · View at Scopus
  180. G. Jiang, B. Mysona, Y. Dun et al., “Expression, subcellular localization, and regulation of sigma receptor in retinal Müller cells,” Investigative Ophthalmology & Visual Science, vol. 47, no. 12, pp. 5576–5582, 2006. View at Publisher · View at Google Scholar · View at Scopus
  181. N. J. Coorey, W. Shen, S. H. Chung, L. Zhu, and M. C. Gillies, “The role of glia in retinal vascular disease,” Clinical & Experimental Optometry, vol. 95, no. 3, pp. 266–281, 2012. View at Publisher · View at Google Scholar · View at Scopus
  182. X. Zhu, Y. Sun, Z. Wang, W. Cui, Y. Peng, and R. Li, “Expression of glial cell line-derived neurotrophic factor and its receptors in cultured retinal Muller cells under high glucose circumstance,” Anatomical Record, vol. 295, no. 3, pp. 532–539, 2012. View at Publisher · View at Google Scholar · View at Scopus
  183. T. Jiang, Q. Chang, Z. Zhao et al., “Melatonin-mediated cytoprotection against hyperglycemic injury in Muller cells,” PLoS ONE, vol. 7, no. 12, Article ID e50661, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  184. X. Ye, H. Ren, M. Zhang, Z. Sun, A. C. Jiang, and G. Xu, “ERK1/2 signaling pathway in the release of VEGF from Müller cells in diabetes,” Investigative Ophthalmology & Visual Science, vol. 53, no. 7, pp. 3481–3489, 2012. View at Publisher · View at Google Scholar · View at Scopus
  185. R. M. Ferrer-Martín, D. Martín-Oliva, A. Sierra et al., “Microglial cells in organotypic cultures of developing and adult mouse retina and their relationship with cell death,” Experimental Eye Research, vol. 121, pp. 42–57, 2014. View at Publisher · View at Google Scholar · View at PubMed
  186. O. S. Gancharova, V. N. Manskikh, A. A. Zamyatnin, and P. P. Philippov, “Organotypic culture of neural retina as a research model of neurodegeneration of ganglion cells,” Biochemistry, vol. 78, no. 11, pp. 1280–1286, 2013. View at Publisher · View at Google Scholar · View at Scopus
  187. G. Thangaraj, A. Greif, and P. G. Layer, “Simple explant culture of the embryonic chicken retina with long-term preservation of photoreceptors,” Experimental Eye Research, vol. 93, no. 4, pp. 556–564, 2011. View at Publisher · View at Google Scholar · View at Scopus
  188. L. Barr-Nea and R. Y. Barishak, “Tissue culture studies of the embryonal chicken retina.,” Investigative ophthalmology, vol. 9, no. 6, pp. 447–457, 1970. View at Google Scholar · View at Scopus
  189. A. R. Caffe, H. Visser, H. G. Jansen, and S. Sanyal, “Histotypic differentiation of neonatal mouse retina in organ culture,” Current Eye Research, vol. 8, no. 10, pp. 1083–1092, 1989. View at Publisher · View at Google Scholar · View at Scopus
  190. L. Gaddini, M. Villa, A. Matteucci et al., “Early effects of high glucose in retinal tissue cultures. Renin-Angiotensin system-dependent and -independent signaling,” Neurobiology of Disease, vol. 35, no. 2, pp. 278–285, 2009. View at Publisher · View at Google Scholar · View at Scopus
  191. S. Kato, S. Madachi-Yamamoto, Y. Hayashi, N. Miki, and K. Negishi, “Effect of sodium fluorescein on neurite outgrowth from the retinal explant culture: an in vitro model for retinal toxicity,” Brain Research, vol. 313, no. 1, pp. 143–147, 1983. View at Google Scholar · View at Scopus
  192. A. R. Caffé, P. Ahuja, B. Holmqvist et al., “Mouse retina explants after long-term culture in serum free medium,” Journal of Chemical Neuroanatomy, vol. 22, no. 4, pp. 263–273, 2001. View at Publisher · View at Google Scholar · View at Scopus
  193. K. Johansson and B. Ehinger, “Structural changes in the developing retina maintained in vitro,” Vision Research, vol. 45, no. 25-26, pp. 3235–3243, 2005. View at Publisher · View at Google Scholar · View at Scopus
  194. J. Mosinger Ogilvie, J. D. Speck, J. M. Lett, and T. T. Fleming, “A reliable method for organ culture of neonatal mouse retina with long- term survival,” Journal of Neuroscience Methods, vol. 87, no. 1, pp. 57–65, 1999. View at Publisher · View at Google Scholar · View at Scopus
  195. G. Pinzon-Duarte, K. Kohler, B. Arango-Gonzalez, and E. Guenther, “Cell differentiation, synaptogenesis, and influence of the retinal pigment epithelium in a rat neonatal organotypic retina culture,” Vision Research, vol. 40, no. 25, pp. 3455–3465, 2000. View at Publisher · View at Google Scholar · View at Scopus
  196. S. Voyatzis, A. Muzerelle, P. Gaspar, and X. Nicol, “Modeling activity and target-dependent developmental cell death of mouse retinal ganglion cells ex vivo,” PLoS ONE, vol. 7, no. 2, Article ID e31105, 2012. View at Publisher · View at Google Scholar · View at Scopus
  197. N. Niyadurupola, P. Sidaway, A. Osborne, D. C. Broadway, and J. Sanderson, “The development of human organotypic retinal cultures (HORCs) to study retinal neurodegeneration,” The British Journal of Ophthalmology, vol. 95, no. 5, pp. 720–726, 2011. View at Publisher · View at Google Scholar · View at Scopus
  198. M. He, H. Pan, C. Xiao, and M. Pu, “Roles for redox signaling by NADPH oxidase in hyperglycemia-induced heme oxygenase-1 expression in the diabetic retina,” Investigative Ophthalmology & Visual Science, vol. 54, no. 6, pp. 4092–4101, 2013. View at Publisher · View at Google Scholar · View at Scopus
  199. T. Oshitari and S. Roy, “Diabetes: a potential enhancer of retinal injury in rat retinas,” Neuroscience Letters, vol. 390, no. 1, pp. 25–30, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  200. Y. Du, A. Veenstra, K. Palczewski, and T. S. Kern, “Photoreceptor cells are major contributors to diabetes-induced oxidative stress and local inflammation in the retina,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 41, pp. 16586–16591, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  201. A. Enzsoly, A. Szabo, O. Kantor et al., “Pathologic alterations of the outer retina in streptozotocin-induced diabetes,” Investigative Ophthalmology & Visual Science, vol. 55, no. 6, pp. 3686–3699, 2014. View at Publisher · View at Google Scholar
  202. J. R. Hombrebueno, M. Chen, R. G. Penalva, and H. Xu, “Loss of synaptic connectivity, particularly in second order neurons is a key feature of diabetic retinal neuropathy in the Ins2Akita mouse,” PLoS ONE, vol. 9, no. 5, Article ID e97970, 2014. View at Publisher · View at Google Scholar · View at Scopus
  203. J. Wisniewska-Kruk, K. A. Hoeben, I. M. C. Vogels et al., “A novel co-culture model of the blood-retinal barrier based on primary retinal endothelial cells, pericytes and astrocytes,” Experimental Eye Research, vol. 96, no. 1, pp. 181–190, 2012. View at Publisher · View at Google Scholar · View at Scopus
  204. X. Zhang, Y. Fu, X. Xu et al., “PERK pathway are involved in NO-induced apoptosis in endothelial cells cocultured with RPE under high glucose conditions,” Nitric Oxide, vol. 40, pp. 10–16, 2014. View at Publisher · View at Google Scholar · View at Scopus